“…Nosocomial infections from multidrug resistant (MDR) Enterococcus alone comprise a serious threat to public health, registering an estimate of 54,500 hospitalizations and 5,400 deaths annually [ ]. MDR bacteria like Enterococci have allowed isolates to survive multiple generations of anti-gram-positive therapeutics ( Miller et al., 2014 ), requiring novel nanotherapeutics including metal oxides such as the chitosan delivering zinc oxide nanocomposites (CZNPs) ( Limayem et al., 2020 ) or silver (Ag) hydrosol ( Sim et al., 2018 ). Vancomycin-resistant E. faecium (VRE ) are increasingly becoming a threat as a nosocomial infection ( Johnston and Jaykus, 2004 ; Puchter et al., 2018 ).…”